当前位置： SCI文献检索 > PHARMACEUTICAL RESEARCH期刊下所有文献 > Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.

Abstract：

PURPOSE:To employ in vitro experiments combined with computational fluid dynamics (CFD) analysis to determine which aerodynamic factors were most responsible for deaggregating carrier-free powders to form micrometer and submicrometer aerosols from a capsule-based platform. METHODS:Eight airflow passages were evaluated for deaggregation of the aerosol including a standard constricted tube, impaction surface, 2D mesh, inward radial jets, and newly proposed 3D grids and rod arrays. CFD simulations were implemented to evaluate existing and new aerodynamic factors for deaggregation and in vitro experiments were used to evaluate performance of each inhaler. RESULTS:For the carrier-free formulation considered, turbulence was determined to be the primary deaggregation mechanism. A strong quantitative correlation was established between the mass median diameter (MMD) and newly proposed non-dimensional specific dissipation (NDSD) factor, which accounts for turbulent energy, inverse of the turbulent length scale, and exposure time. A 3D rod array design with unidirectional elements maximized NDSD and produced the best deaggregation with MMD<1 μm. CONCLUSIONS:The new NDSD parameter can be used to develop highly effective dry powder inhalers like the 3D rod array that can efficiently produce submicrometer aerosols for next-generation respiratory drug delivery applications.

journal_name

Pharm Res

journal_title

Pharmaceutical research

authors

Longest PW,Son YJ,Holbrook L,Hindle M

doi

10.1007/s11095-013-1001-z

subject

Has Abstract

pub_date

2013-06-01 00:00:00

pages

1608-27

issue

6

eissn

0724-8741

issn

1573-904X

journal_volume

30

pub_type

杂志文章

相关文献

PHARMACEUTICAL RESEARCH文献大全
  • Controlled delivery systems for proteins using polyanhydride microspheres.

    abstract：:A method to provide near-constant sustained release of high molecular weight, water-soluble proteins from polyanhydride microspheres is described. The polyanhydrides used were poly(fatty acid dimer) (PFAD), poly(sebacic acid) (PSA), and their copolymers [P(FAD-SA)]. P(FAD-SA) microspheres containing proteins of differ...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1018929531410

    authors： Tabata Y,Gutta S,Langer R

    更新日期：1993-04-01 00:00:00

  • Synthesis and calcium channel antagonist activity of 3-arylmethyl 5-isopropyl 1,4-dihydro-2,6-dimethyl-4-(pyridyl)-3,5-pyridinedicarboxylates.

    abstract：:Unsymmetrical aryl(heteroaryl)methyl isopropyl ester analogues of nifedipine, in which the 2-nitrophenyl group at C-4 is replaced by a 2- or 3-pyridyl substituent, were synthesized and evaluated as calcium-channel antagonists using guinea pig ileal longitudinal smooth muscle. The point of attachment of the C-4 pyridyl...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1015941706008

    authors： Akula MR,Matowe WC,Wolowyk MW,Knaus EE

    更新日期：1990-09-01 00:00:00

  • Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.

    abstract：PURPOSE:[corrected] The purpose of this study was to design novel gastroretentive dosage forms (GRDFs) based on unfolding multilayer polymeric films, to investigate the mechanism of their gastroretentivity in dogs, and to assess the effect of compounding a narrow absorption window drug in a GRDF on the drug's absorptio...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1020412817716

    authors： Klausner EA,Lavy E,Stepensky D,Friedman M,Hoffman A

    更新日期：2002-10-01 00:00:00

  • Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy.

    abstract：PURPOSE:A patient was denoted to be generic brittle (GB) if they had a negative opinion about generics (e.g. prior history of a switch problem) or took the innovator brand of their most problematic anti-epileptic drug (AED) when generic was available. The aim of this hypothesis-generating study was to assess possible g...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-020-2781-6

    authors： Das S,Guo D,Jiang X,Jiang W,Shu Y,Ting TY,Polli JE

    更新日期：2020-02-26 00:00:00

  • Gamma irradiation of active self-healing PLGA microspheres for efficient aqueous encapsulation of vaccine antigens.

    abstract：PURPOSE:To investigate the effect of γ-irradiation of poly(lactic-co-glycolic acid) (PLGA)/Al(OH)₃/0 or 5 wt% diethyl phthalate (DEP) microspheres for active self-healing encapsulation of vaccine antigens. METHODS:Microspheres were irradiated with ⁶⁰Co at 2.5 and 1.8 MRad and 0.37 and 0.20 MRad/h. Encapsulation of tet...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-013-1019-2

    authors： Desai KG,Kadous S,Schwendeman SP

    更新日期：2013-07-01 00:00:00

  • Grapefruit juice activates P-glycoprotein-mediated drug transport.

    abstract：PURPOSE:Grapefruit juice (GJ) is known to increase the oral bioavailability of many CYP3A-substrates by inhibiting intestinal phase-I metabolism. However, the magnitude of AUC increase is often insignificant and highly variable. Since we earlier suggested that CYP3A and P-glycoprotein (P-gp) form a concerted barrier to...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1011902625609

    authors： Soldner A,Christians U,Susanto M,Wacher VJ,Silverman JA,Benet LZ

    更新日期：1999-04-01 00:00:00

  • Reaction to the paper: interaction of polysorbate 80 with erythropoietin: a case study in protein-surfactant interactions.

    abstract：:Micelle-associated epoetin is still a possible explanation for the upsurge of pure red blood cell aplasia associated with subcutaneous use of epoetin alpha in patients with chronic renal failure. ...

    journal_title：Pharmaceutical research

    pub_type： 评论,信件

    doi：10.1007/s11095-006-9573-5

    authors： Hermeling S,Jiskoot W,Crommelin DJ,Schellekens H

    更新日期：2006-03-01 00:00:00

  • Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.

    abstract：PURPOSE:The purpose of this study was to evaluate the feasibility of delivering vapreotide, a somatostatin analogue, by transdermal iontophoresis. METHODS:In vitro experiments were conducted using dermatomed porcine ear skin and heat-separated epidermis. In addition to quantifying vapreotide transport into and across ...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-005-5276-6

    authors： Schuetz YB,Naik A,Guy RH,Vuaridel E,Kalia YN

    更新日期：2005-08-01 00:00:00

  • Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.

    abstract：PURPOSE:To characterize temporal exposure and elimination of 5 gold/dendrimer composite nanodevices (CNDs) (5 nm positive, negative, and neutral, 11 nm negative, 22 nm positive) in mice using a physiologically based mathematical model. METHODS:400 ug of CNDs is injected intravenously to mice bearing melanoma cell line...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-012-0784-7

    authors： Mager DE,Mody V,Xu C,Forrest A,Lesniak WG,Nigavekar SS,Kariapper MT,Minc L,Khan MK,Balogh LP

    更新日期：2012-09-01 00:00:00

  • The use of multiple doses and pharmacodynamic system analysis to distinguish between dispositional delays and time-variant pharmacodynamics.

    abstract：:Pharmacokinetic-pharmacodynamic modeling algorithms, in general, rely on hysteresis minimization techniques that assume time-invariant pharmacodynamics (constant biophase concentration-effect relationships). When time-variant pharmacodynamics are observed, a specific model for tolerance or sensitization is required. H...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1018940122382

    authors： Gastonguay MR,Schwartz SL

    更新日期：1994-12-01 00:00:00

  • Development of an Improved Inhalable Powder Formulation of Pirfenidone by Spray-Drying: In Vitro Characterization and Pharmacokinetic Profiling.

    abstract：PURPOSE:Previously, a respirable powder (RP) formulation of pirfenidone (PFD) was developed for reducing phototoxic risk; however, PFD-RP demonstrated unacceptable in vitro inhalation performance. The present study aimed to develop a new RP system of PFD with favorable inhalation properties by spray-drying method. MET...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-016-1887-3

    authors： Seto Y,Suzuki G,Leung SS,Chan HK,Onoue S

    更新日期：2016-06-01 00:00:00

  • Disparity of in vitro and in vivo oleic acid-enhanced beta-estradiol percutaneous absorption across human skin.

    abstract：:The permeation enhancing property of 5% oleic acid in ethanol on beta-estradiol was investigated in vitro and in vivo using symmetrical and asymmetrical side-by-side diffusion cells and the human skin sandwich flap, respectively. beta-Estradiol permeability in vitro and in vivo was similar in 75% ethanol (ETOH). Oleic...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1018974131236

    authors： Pershing LK,Parry GE,Lambert LD

    更新日期：1993-12-01 00:00:00

  • Improved pharmacokinetic and biodistribution properties of the selective urokinase inhibitor PAI-2 (SerpinB2) by site-specific PEGylation: implications for drug delivery.

    abstract：PURPOSE:Overexpression of the serine protease urokinase (uPA) is recognised as an important biomarker of metastatic disease and a druggable anticancer target. Plasminogen activator inhibitor type-2 (PAI-2/SerpinB2) is a specific uPA inhibitor with proven potential for use in targeted therapy. However, PAI-2 is rapidly ...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-014-1517-x

    authors： Vine KL,Lobov S,Indira Chandran V,Harris NL,Ranson M

    更新日期：2015-03-01 00:00:00

  • High Content Solid Dispersions for Dose Window Extension: A Basis for Design Flexibility in Fused Deposition Modelling.

    abstract：PURPOSE:This study uses high drug content solid dispersions for dose window extension beyond current demonstrations using fused deposition modelling (FDM) to; i) accommodate pharmaceutically relevant doses of drugs of varying potencies at acceptable dosage form sizes and ii) enable enhanced dose flexibility via modular...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-019-2720-6

    authors： Govender R,Abrahmsén-Alami S,Folestad S,Larsson A

    更新日期：2019-12-17 00:00:00

  • Saquinavir Loaded Acetalated Dextran Microconfetti - a Long Acting Protease Inhibitor Injectable.

    abstract：PURPOSE:Since the adoption of highly active antiretroviral therapy, HIV disease progression has slowed across the world; however, patients are often required to take multiple medications daily of poorly bioavailable drugs via the oral route, leading to gastrointestinal irritation. Recently, long acting antiretroviral i...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-016-1936-y

    authors： Collier MA,Gallovic MD,Bachelder EM,Sykes CD,Kashuba A,Ainslie KM

    更新日期：2016-08-01 00:00:00

  • Divergent effects of raloxifene HCI on the pharmacokinetics and pharmacodynamics of warfarin.

    abstract：PURPOSE:Evista (raloxifene HCl) is a nonsteroidal selective estrogen receptor modulator that displays estrogen agonist effects on bone and lipid metabolism but estrogen antagonist effects on the breast and endometrium. The potential for drug-drug interaction between raloxifene and warfarin was assessed in 15 healthy po...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1010904815275

    authors： Miller JW,Skerjanec A,Knadler MP,Ghosh A,Allerheiligen SR

    更新日期：2001-07-01 00:00:00

  • Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.

    abstract：PURPOSE:To investigate the ability of various polymers to inhibit the crystallization of amorphous felodipine from amorphous molecular dispersions in the presence of absorbed moisture. METHODS:Spin coated films of felodipine with poly(vinylpyrrolidone) (PVP), hydroxypropylmethylcellulose acetate succinate (HPMCAS) and...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-007-9331-3

    authors： Konno H,Taylor LS

    更新日期：2008-04-01 00:00:00

  • In Vivo Stability of Therapeutic Proteins.

    abstract：:Significant efforts are made to characterize molecular liabilities and degradation of the drug substance (DS) and drug product (DP) during various product life-cycle stages. The in vivo fate of a therapeutic protein is usually only considered in terms of pharmacokinetics (PKs) and pharmacodynamics (PDs). However, the ...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章,评审

    doi：10.1007/s11095-019-2689-1

    authors： Schuster J,Koulov A,Mahler HC,Detampel P,Huwyler J,Singh S,Mathaes R

    更新日期：2020-01-03 00:00:00

  • Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique.

    abstract：PURPOSE:The aim of this study was to investigate whether biodegradable nanocapsules could be obtained by the emulsification-diffusion technique. METHODS:This technique consists of emulsifying an organic solution containing an oil, a polymer, and a drug in an aqueous solution of a stabilizing agent. The subsequent addi...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1011934328471

    authors： Quintanar-Guerrero D,Allémann E,Doelker E,Fessi H

    更新日期：1998-07-01 00:00:00

  • Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model.

    abstract：PURPOSE:The objective of this investigation was to determine, using the Caco-2 cell culture model, the extent to which the paracellular and transcellular routes contributed to the transport of passively absorbed drugs. An effort was also made to determine the controlling factors in this process. METHODS:We selected a ...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1012111008617

    authors： Pade V,Stavchansky S

    更新日期：1997-09-01 00:00:00

  • Purification and identification of high molecular weight products formed during storage of neutral formulation of human insulin.

    abstract：PURPOSE:To identify High Molecular Weight Products (HMWP) formed in human insulin formulation during storage. METHODS:Commercial formulation of human insulin was stored at 37°C for 1 year and HMWP was isolated using preparative size exclusion chromatography (SEC) and reverse phase (RP) chromatography. The primary stru...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-014-1600-3

    authors： Hjorth CF,Hubálek F,Andersson J,Poulsen C,Otzen D,Naver H

    更新日期：2015-06-01 00:00:00

  • Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation.

    abstract：PURPOSE:To show, using a model study, how electronic structure theory can be applied in combination with LC/UV/MS/MS for the prediction and identification of oxidative degradants. METHODS:The benzyloxazole 1, was used to represent an active pharmaceutical ingredient for oxidative forced degradation studies. Bond disso...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/b:pham.0000041469.96466.12

    authors： Reid DL,Calvitt CJ,Zell MT,Miller KG,Kingsmill CA

    更新日期：2004-09-01 00:00:00

  • Prolonged blood circulation in rats of nanospheres surface-modified with semitelechelic poly[N-(2-hydroxypropyl)methacrylamide].

    abstract：:Semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]s (ST-PHPMA) containing one amino end-group and differing in molecular weight were synthesized by radical polymerization in the presence of 2-aminoethanethiol (AET) as chain transfer agent. These polymers were covalently attached via amide bonds to the surface of n...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1016247206531

    authors： Kamei S,Kopecek J

    更新日期：1995-05-01 00:00:00

  • 16HBE14o- human bronchial epithelial cell layers express P-glycoprotein, lung resistance-related protein, and caveolin-1.

    abstract：PURPOSE:To study the expression of P-glycoprotein (P-gp), lung resistance-related protein (LRP), and caveolin-1 (cav-1) in the human bronchial epithelial cell line 16HBE14o-. METHODS:The presence of P-gp, LRP, and cav-1 in 16HBE14o- cell layers was evaluated using immunocytochemical staining and visualization with con...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1023230328687

    authors： Ehrhardt C,Kneuer C,Laue M,Schaefer UF,Kim KJ,Lehr CM

    更新日期：2003-04-01 00:00:00

  • A mechanism enhancing macromolecule transport through paracellular spaces induced by Poly-L-Arginine: Poly-L-Arginine induces the internalization of tight junction proteins via clathrin-mediated endocytosis.

    abstract：PURPOSE:Poly-L-arginine (PLA) enhances the paracellular permeability of the Caco-2 cell monolayer to hydrophilic macromolecules by disappearance of tight junction (TJ) proteins from cell-cell junctions. However, the mechanism of the disappearance of TJ proteins in response to PLA has been unclear. In this study, we inv...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-014-1324-4

    authors： Yamaki T,Kamiya Y,Ohtake K,Uchida M,Seki T,Ueda H,Kobayashi J,Morimoto Y,Natsume H

    更新日期：2014-09-01 00:00:00

  • Systemic delivery of cetrorelix to rats by a new aerosol delivery system.

    abstract：PURPOSE:To study the pulmonary absorption and tolerability of various formulations of the decapeptide cetrorelix acetate in rats by a new aerosol delivery system (ASTA-ADS) for intratracheal application. METHODS:Using the ASTA-ADS, cetrorelix liquid formulations (aqueous solutions for ultrasonic nebulization) were fir...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1011028227155

    authors： Lizio R,Klenner T,Sarlikiotis AW,Romeis P,Marx D,Nolte T,Jahn W,Borchard G,Lehr CM

    更新日期：2001-06-01 00:00:00

  • Dependence of dissolution rate on surface area: is a simple linear relationship valid for co-compressed drug mixtures?

    abstract：:A quantitative analysis of the dependence of dissolution rate on the relative surface area occupied by two non-interacting drug mixtures from co-compressed slabs is described. The results from the experimental dissolution rates of each component from naproxen/phenytoin co-compressed slabs under laminar flow conditions...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1018979419714

    authors： Neervannan S,Southard MZ,Stella VJ

    更新日期：1994-10-01 00:00:00

  • Glucuronidation metabolic kinetics of valproate in guinea pigs: nonlinear at clinical concentration levels.

    abstract：PURPOSE:Nonlinear conjugation metabolic rate of valproic acid (VPA) has been speculated previously from plasma elimination and liver concentration of VPA in guinea pigs. The purposes of the present study were to assess our speculation by direct measurement of VPA glucuronidation rate in vitro. METHODS:VPA at various c...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1023/a:1016028707130

    authors： Yu HY,Shen YZ

    更新日期：1996-08-01 00:00:00

  • Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug.

    abstract：PURPOSE:Recent studies have demonstrated the potential for a triglyceride (TG) mimetic prodrug to promote the delivery of mycophenolic acid (MPA) to the lymphatic system. Here, the metabolic pathways that facilitate the lymphatic transport of the TG prodrug (1,3-dipalmitoyl-2-mycophenoloyl glycerol, 2-MPA-TG) were exam...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-014-1579-9

    authors： Han S,Hu L,Quach T,Simpson JS,Trevaskis NL,Porter CJ

    更新日期：2015-05-01 00:00:00

  • Solid lipid nanoparticles as delivery systems for bromocriptine.

    abstract：PURPOSE:The present investigation describes a formulative study for the development of innovative drug delivery systems for bromocriptine. METHODS:Solid lipid nanoparticles (SLN) based on different lipidic components have been produced and characterized. Morphology and dimensional distribution have been investigated b...

    journal_title：Pharmaceutical research

    pub_type： 杂志文章

    doi：10.1007/s11095-007-9514-y

    authors： Esposito E,Fantin M,Marti M,Drechsler M,Paccamiccio L,Mariani P,Sivieri E,Lain F,Menegatti E,Morari M,Cortesi R

    更新日期：2008-07-01 00:00:00